Indeed, albeit in vitro studies have proposed both pro-neoplastic [37, 38] and anti-neoplastic [39] roles for ATGL, the current in vivo observations indicate that ATGL is reduced in pancreatic adenocarcinoma [17] and in several other cancer types [16]. This evidence concerns the gene PNPLA2 and pancreatic adenocarcinoma.